Northern Trust’s Immunome IMNM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $6.43M | Sell |
691,557
-6,844
| -1% | -$63.6K | ﹤0.01% | 2323 |
|
2025
Q1 | $4.7M | Buy |
698,401
+181,910
| +35% | +$1.22M | ﹤0.01% | 2443 |
|
2024
Q4 | $5.49M | Buy |
516,491
+43,146
| +9% | +$458K | ﹤0.01% | 2456 |
|
2024
Q3 | $6.92M | Buy |
473,345
+303,096
| +178% | +$4.43M | ﹤0.01% | 2289 |
|
2024
Q2 | $2.06M | Buy |
170,249
+34,761
| +26% | +$421K | ﹤0.01% | 2882 |
|
2024
Q1 | $3.34M | Buy |
135,488
+35,260
| +35% | +$870K | ﹤0.01% | 2712 |
|
2023
Q4 | $1.07M | Buy |
100,228
+83,763
| +509% | +$896K | ﹤0.01% | 3293 |
|
2023
Q3 | $137K | Sell |
16,465
-245
| -1% | -$2.05K | ﹤0.01% | 3930 |
|
2023
Q2 | $132K | Sell |
16,710
-88
| -0.5% | -$696 | ﹤0.01% | 3962 |
|
2023
Q1 | $83.8K | Hold |
16,798
| – | – | ﹤0.01% | 4120 |
|
2022
Q4 | $37.1K | Hold |
16,798
| – | – | ﹤0.01% | 4356 |
|
2022
Q3 | $75K | Hold |
16,798
| – | – | ﹤0.01% | 4209 |
|
2022
Q2 | $54K | Hold |
16,798
| – | – | ﹤0.01% | 4381 |
|
2022
Q1 | $95K | Hold |
16,798
| – | – | ﹤0.01% | 4355 |
|
2021
Q4 | $218K | Hold |
16,798
| – | – | ﹤0.01% | 4170 |
|
2021
Q3 | $409K | Buy |
+16,798
| New | +$409K | ﹤0.01% | 3845 |
|
2021
Q2 | – | Sell |
-27,114
| Closed | -$918K | – | 4611 |
|
2021
Q1 | $918K | Buy |
27,114
+1,827
| +7% | +$61.9K | ﹤0.01% | 3618 |
|
2020
Q4 | $245K | Buy |
+25,287
| New | +$245K | ﹤0.01% | 3920 |
|